Furthermore, increased STAT3 signaling has been linked to chemoresistance in pancreatic cancer and targeting STAT3 signaling synergizes with gemcitabine chemotherapy in mouse models of PDAC38. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.